Cephalochromin, a FabI-directed antibacterial of microbial origin
Authors:
- Young-Soo HongYHYoung-Soo Hong
- Won-Gon KimWKWon-Gon Kim
- 1 November 2007
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 362 (4) , 1107-1112
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Inhibition ofPlasmodiumfalciparumFatty Acid Biosynthesis: Evaluation of FabG, FabZ, and FabI as Drug Targets for FlavonoidsJournal of Medicinal Chemistry, 2006
- Platensimycin is a selective FabF inhibitor with potent antibiotic propertiesNature, 2006
- Fatty acid synthesis is a target for antibacterial activity of unsaturated fatty acidsFEBS Letters, 2005
- Evaluation of Epigallocatechin Gallate and Related Plant Polyphenols as Inhibitors of the FabG and FabI Reductases of Bacterial Type II Fatty-acid SynthaseJournal of Biological Chemistry, 2004
- Identification and Characterization of Inhibitors of Bacterial Enoyl-Acyl Carrier Protein ReductaseAntimicrobial Agents and Chemotherapy, 2004
- Structure−Activity Studies of the Inhibition of FabI, the Enoyl Reductase from Escherichia coli, by Triclosan: Kinetic Analysis of Mutant FabIsBiochemistry, 2003
- Indole Naphthyridinones as Inhibitors of Bacterial Enoyl-ACP Reductases FabI and FabKJournal of Medicinal Chemistry, 2003
- Discovery of a Novel and Potent Class of FabI-Directed Antibacterial AgentsAntimicrobial Agents and Chemotherapy, 2002
- Bacterial Fatty Acid Biosynthesis: Targets for Antibacterial Drug DiscoveryAnnual Review of Microbiology, 2001
- Modification of the NADH of the Isoniazid Target (InhA) from Mycobacterium tuberculosisScience, 1998